Raubling, Germany-based Axplora, which focuses on small-molecule API manufacturing reports that its total investments ...

These pressures demand more resilient, forward-looking sourcing strategies. This article explores practical approaches to safeguarding API quality and availability. Key considerations include rigorous ...

AbbVie started construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago, Illinois.

This latest FDA program aims to provide speedier reviews for generic drugmakers who produce their products in the U.S.

Reshoring generic pharmaceutical production is essential in today’s era of geopolitical instability and heightened awareness ...

European drugmakers will struggle to bring production back to the region, but the industry needs to diversify supplies to avoid shortages, a top EU official said on Wednesday, as worries grow about ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...

AbbVie (ABBV) announced the start of construction of its new active pharmaceutical ingredient manufacturing plant in North ...

The convergence of biopharmaceutical innovation, contract manufacturing partnerships, and advanced synthesis technologies is redefining how drugs are developed, manufactured, and delivered worldwide N ...

The US administration has been weighing duties on pharma drugs and APIs under Section 232, which is used to investigate ...

A local nonprofit working to strengthen the U.S. drug ingredient supply chain says external forces are making drug shortages ...